氯谷胺
|
|
|
- CAS号:
- 107097-80-3
- 英文名:
- LOXIGLUMIDE
- 英文别名:
- cr1505;CS-162;anoicacid;ntanoicacid;(+-)--5-oxo;LOXIGLUMIDE;Loxiglumide, >98%;LoxigluMide (CR1505);Loxiglumide >=97% (HPLC);d,l-4-(3,4-dichlorobenzoylamino)-5-(n-3-methoxypropylpentylamino)-5-oxo-pent
- 中文名:
- 氯谷胺
- 中文别名:
- 氯谷胺;氯谷胺, >98%;LOXIGLUMIDE,CCK1拮抗剂;4-(3,4-二氯苯甲酰胺基)-5-((3-甲氧基丙基)(戊基)氨基)-5-氧代戊酸
- CBNumber:
- CB0326090
- 分子式:
- C21H30Cl2N2O5
- 分子量:
- 461.38
- MOL File:
- 107097-80-3.mol
|
|
|
氯谷胺化学性质
-
熔点:
-
113-115℃
-
|
-
沸点:
-
632.2±55.0 °C(Predicted)
-
|
-
密度:
-
1.233±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO: ≥5mg/mL
-
|
-
酸度系数(pKa):
-
pKa ~5(at 25℃)
-
|
-
形态:
-
powder
-
|
-
颜色:
-
white to beige
-
|
-
CAS 数据库:
-
107097-80-3
-
|
氯谷胺性质、用途与生产工艺
Loxiglumide 是缩胆囊素 (CCK-1) 受体拮抗剂。
The effects of pancreatic rest by oral administration of CCK-1 receptor antagonist Loxiglumide and pancreas stimulation are investigated via endogenous CCK release induced by po protease inhibitor camostat on the recovery of pancreatic secretory function, and biochemical and histological changes of the pancreas after acute hemorrhagic pancreatitis. Oral administration of CCK-1 receptor antagonist Loxiglumide with a dose of 50 mg/kg body weight inhibits pancreatic exocrine secretion for more than 12 h. Thus, every 12-h administration of Loxiglumide might have completely blocks the effect of endogenously released CCK on the pancreas (pancreatic rest).
氯谷胺
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-B2154 | Loxiglumide | | 5 mg | 360元 |
| 2024/01/25 | HY-B2154 | 氯谷胺
Loxiglumide | 107097-80-3 | 10mM * 1mLin DMSO | 365元 |
氯谷胺
生产厂家
全球有 71家供应商
氯谷胺国内生产厂家
107097-80-3, 氯谷胺 相关搜索:
- Inhibitors
- 合成有机化合物配体
- 小分子抑制剂
- 小分子抑制剂，天然产物
- C21H30Cl2N2O5
- 4-(3,4-二氯苯甲酰胺基)-5-((3-甲氧基丙基)(戊基)氨基)-5-氧代戊酸
- LOXIGLUMIDE,CCK1拮抗剂
- 氯谷胺, >98%
- 氯谷胺
- 107097-80-3
- 4-(3,4-Dichlorobenzamido)-5-((3-methoxypropyl)(pentyl)amino)-5-oxopentanoicacid
- CR1505,CR 1505,CCK Receptor,Inhibitor,Loxiglumide,inhibit,Cholecystokinin Receptor
- Loxiglumide >=97% (HPLC)
- Pentanoic acid, 4-[(3,4-dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxo-
- Loxiglumide, >98%
- CS-162
- pentanoicacid,4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)
- ntanoicacid
- d,l-4-(3,4-dichlorobenzoylamino)-5-(n-3-methoxypropylpentylamino)-5-oxo-pent
- cr1505
- anoicacid
- (+-)--5-oxo
- (+-)-4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)-5-oxope
- LOXIGLUMIDE
- LoxigluMide (CR1505)
- 5-[amyl(3-methoxypropyl)amino]-4-[(3,4-dichlorobenzoyl)amino]-5-keto-valeric acid
- 4-[(3,4-dichlorophenyl)carbonylamino]-5-[3-methoxypropyl(pentyl)amino]-5-oxo-pentanoic acid
- 4-[(3,4-dichlorobenzoyl)amino]-5-[3-methoxypropyl(pentyl)amino]-5-oxopentanoic acid